Black Rock Inc. Hille Vax, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Hille Vax, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,090,604 shares of HLVX stock, worth $4.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,090,604
Previous 1,800,277
16.13%
Holding current value
$4.03 Million
Previous $29.9 Million
0.98%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding HLVX
# of Institutions
80Shares Held
36.7MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$20.5 Million9.05% of portfolio
-
Tang Capital Management LLC San Diego, CA4.92MShares$9.5 Million0.74% of portfolio
-
Franklin Resources Inc San Mateo, CA1.96MShares$3.78 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.88MShares$3.63 Million0.06% of portfolio
-
Carlyle Group Inc. Washington, DC1.84MShares$3.55 Million0.49% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $64.5M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.